HOME >> MEDICINE >> NEWS
Weizmann Institute Prof. Moshe Oren named winner of NIH MERIT Award

Washington, D.C.--Prof. Moshe Oren, a cancer researcher at the Weizmann Institute of Science in Israel, was named a 2003 winner of the highly selective MERIT (Method to Extend Research in Time) Award. The award is granted by the National Institutes of Health (NIH) for "long-term support to investigators with impressive records of scientific achievement in research areas of special importance or promise."

The NIH hopes the MERIT Award will encourage scientists to "take greater risks, be more adventurous in the lines of inquiry, or take the time to develop new techniques." Less than five percent of NIH investigators are selected to receive the MERIT Award, which provides long-term support for researchers, freeing them from the burden of securing and renewing funding for their work year after year. The award has been presented annually since 1987 to individuals whose "paradigm shifting ideas" and "excellent productivity" make them leaders in their field.

Prof. Oren's research gained the attention of the cancer research world in the early 1980s for his role in cloning p53, the "tumor suppressor gene." Since that time, p53 has been the object of intense scientific scrutiny. It soon became clear that p53 is a part of a complex molecular network, that can suppress -- or fail to suppress -- cancerous growth.

The discovery of p53 and its key role in maintaining healthy cells led to a burgeoning new direction in cancer research. Although it is not the only tumor suppressor gene, mutations in the p53 gene are most common in cancer. In normal cells, p53 sets in motion a complex series of molecular events that can cause cell suicide, or apoptosis -- which, despite its name, is a necessary and healthy mechanism that prevents damaged cells from replicating possibly cancerous mistakes in their DNA. When p53 does not function properly, cancerous cells do not undergo apoptosis, and are able to proliferate in the body. Understanding how p53 works, and
'"/>

Contact: Jeffrey J. Sussman
Jeffrey@acwis.org
212-895-7951
American Committee for the Weizmann Institute of Science
11-Nov-2003


Page: 1 2

Related medicine news :

1. Weizmann Institute receives $8 million grant from Flight Attendant Medical Research Institute
2. Weizmann Women & Science Award to be presented to Dr. Carla J. Shatz; Millennial Lifetime Achievement Award to Dr. Mildred S. Dresselhaus
3. Weizmann Institute scientists develop a potential future treatment for myasthenia gravis
4. Gladstone Institutes rank high in the scientist survey of best places for postdocs
5. Institute of Medicine advisory: Jan. 12 Briefing on Complementary and Alternative Medicine
6. Research by scientists affiliated with the Earth Institute at Columbia University
7. New Jersey Institute of Technology pioneers new way to teach engineers
8. Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO
9. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
10. American College of Chest Physicians announces new Critical Care Institute
11. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... ... a highly specialized asset-light logistics provider of complex transport solutions for mission-critical ... to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. ...
(Date:8/18/2017)... ... 18, 2017 , ... August 18, 2017 — Mediaplanet today ... active, healthy lifestyles and highlighting the importance of proactive eye and ear health ... shares the latest innovations in hearing aid technology. , According to the ...
(Date:8/18/2017)... ... 18, 2017 , ... As an industry leader, Eppendorf is ... will present the line of epMotion automated liquid handling system. This automated liquid ... everyday pipetting tasks. , Ideal for scientists and lab technicians with no or ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, ... communities throughout the greater DC region, is inaugurating a “New Leash On Life” ... animals and training them to be companions for veterans in need. , The ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... WILMINGTON, N.C. , Aug. 15, 2017 ... Wilmington, NC , today announced that the company ... at the University of North Carolina at Chapel Hill ... AccuKit-HIV is designed to characterize and quantify HIV reservoir ... and after pharmacological intervention. The HIV Cure Center is ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced ... comparisons, unless otherwise noted, are to the quarter ended June ... Quarter 2017 Highlights include: Revenue of ... Total prescriptions dispensed of 220,000, compared to ... Gross profit per prescription dispensed of ...
Breaking Medicine Technology:
Cached News: